Infection prevention
limitations reflect the state of the field itself: contemporary AI IPC practice is evolving faster than the formal clinical-outcomes literature.
Conclusion AI has a credible and growing role in hospital infection prevention and control, particularly in data-rich systems such as the NHS. The strongest immediate use cases are likely to be automated surveillance, AMR forecasting, CDI- oriented stewardship support and early-warning tools embedded within EPR workflows. England’s national surveillance and policy infrastructure provide a major implementation advantage, allowing AI programmes to be aligned to existing HCAI objectives and measured against established baselines. There is promising evidence that AI can
improve surveillance efficiency, enhance hand-hygiene measurement, forecast AMR and reduce selected high-risk antimicrobial use. By contrast, robust UK evidence showing that AI has already reduced MRSA, CDI or Gram- negative bloodstream infection burden at scale remains limited. For hospital leaders and IPC teams, the implication is clear: AI should be implemented as part of carefully designed, evaluable intervention systems, not as a stand- alone technology acquisition.
(Basel). 2025; 5;15(17):2138. doi: 10.3390/ diagnostics15172138
6. UK Health Security Agency. Annual epidemiological commentary: Gram- negative, MRSA, MSSA bacteraemia and C. difficile infections, up to and including financial year 2024 to 2025. Updated 24th February 2026:
https://www.gov.uk/ government/statistics/mrsa-mssa-and-e- coli-bacteraemia-and-c-difficile-infection- annual-epidemiological-commentary/ annual-epidemiological-commentary-gram- negative-mrsa-mssa-bacteraemia-and-c- difficile-infections-up-to-and-including- financial-year-2024-to-2025
7. Otu, A., Chudasama, D., Hope, R., Jeyaratnam, D. Data for action: the crucial role of hospitals in controlling Clostridioides difficile infection in England, The Lancet Microbe, 2025; 16 (2):
https://doi.org/10.1016/j.lanmic.2024.100991
8. El Arab RA, Almoosa Z, Alkhunaizi M, et al. J (2025) Artificial intelligence in hospital infection prevention: an integrative review. Front. Public Health 13:1547450. doi: 10.3389/ fpubh.2025.1547450
CSJ
References 1. Bermond, B.C, et al. (2026). IoT and Computer Vision Applied to Monitoring Hand Hygiene in Hospital Environments: An Experience Report. In: Pereira, L., Krus, P., Klofsten, M. (eds) Beyond Boundaries: Unleashing Innovation with Ideas. IDEAS 2024. Design Science and Innovation. Springer, Cham.
https://doi.org/10.1007/978-3- 031-96173-1_27
2. UK Health Security Agency. Healthcare- associated infections (HCAI) statistics (accessed 25th June 2026): https://www.
gov.uk/government/collections/healthcare- associated-infections-hcai-statistics
3. NHS England. National infection prevention and control manual (NIPCM) for England, version 2.12 (2025):
https://www.england.nhs.uk/ national-infection-prevention-and-control- manual-nipcm-for-england/
4. Saad AA, Hassan A, Alali A, et al. The Role of Artificial Intelligence in Managing Central Line- Associated Bloodstream Infection (CLABSI) for Patient Safety and Quality of Care. Risk Manag Healthc Policy. 2025;18:2887-2898. doi: 10.2147/ RMHP.S520035
5. Luchian N, Salim C, Condratovici AP, et al. Episode- and Hospital-Level Modeling of Pan- Resistant Healthcare-Associated Infections (2020-2024) Using TabTransformer and Attention-Based LSTM Forecasting. Diagnostics
9. Gastaldi S, Satta G, Tartari E, et al. Global adoption and readiness for artificial intelligence and digital health technologies in infection prevention and control: a World Health Organization global survey, Journal of Hospital Infection, 2026; 173, 203-210
10. Dong F, Zhang Y, Chen W, et al. Disease classification via interpretable machine learning based on multi-center routine coagulation test. Front Mol Biosci. 2026;13:1788536. doi: 10.3389/ fmolb.2026.1788536
11. Flynn, L. Improving Hospital Hand Hygiene: The Solution May Lie with AI, Standford Medicine, August 2020:
https://med.stanford.edu/cerc/ publications/cerc-articles/improving-hospital-
hand-hygiene.html
12. Anon. Intelligent Hand Hygiene Support, Standford Medicine, accessed 26th June 2026:
https://med.stanford.edu/pacresearch/ research/
hand-hygiene.html
13. Anon. Sanome Partners With NHS Trusts to Deploy AI-Powered Clinical Intelligence for Earlier Infection Detection, Bio Focus, accessed 26th June 2026:
https://www.bio-focus.co.uk/ health/sanome-announces-two-uk-hospital- partnerships-to-deploy-ai-powered-clinical- intelligence-for-earlier-infection-detection
14. Anon. Exeter leads major new project to advance AI-enabled platform for early detection of hospital acquired infections, Health Tech Digital, 9th March 2026:
https://healthtechdigital.com/ exeter-leads-major-new-project-to-advance- ai-enabled-platform-for-early-detection-of- hospital-acquired-infections/
15. Bahru TT, Gobena MA, Anteneh BT, Meskelu HA, Legese AT, Berhanu HT, Aschenaki WK, Zehredin EE, Dawud AS, Wakshume AA, Biyazn TT, Umer YS. Prevalence of Surgical Site Infection and Associated Factors Among Post-Operative Patients. Int Wound J. 2025;22(7):e70730. doi: 10.1111/iwj.70730
16. Songsong Luo, Jiawei Lai, Lujiao Mo, Xiaoyuan Shen, Riliang Fang, Prediction of hospital mortality in sepsis-associated acute kidney injury using a machine-learning approach: a multicenter study using SHAP interpretability analysis, Clinical Kidney Journal, 2026; 19(1):
https://doi.org/10.1093/ckj/sfaf372
17. Norori N, Hu Q, Aellen FM, et al. Addressing bias in big data and AI for health care: A call for open science. Patterns (N Y). 2021;2(10):100347. doi: 10.1016/
j.patter.2021
18. Stoesser N, Emary K, Soklin S, et al. The value of intermittent point-prevalence surveys of healthcare-associated infections for evaluating infection control interventions at Angkor Hospital for Children, Siem Reap, Cambodia. Trans R Soc Trop Med Hyg. 2013;107(4):248-53. doi: 10.1093/trstmh/trt005
19. Talianu A, Fraser-Krauss O, Bolton W, et al. Artificial intelligence for improving decision- making in bacterial infection management: a narrative review. J Antimicrob Chemother. 2026;81(1):dkaf470. doi: 10.1093/jac/dkaf470
20. Tang S, Shepard S, Clark R, et al. Guiding Clostridioides difficile Infection Prevention Efforts in a Hospital Setting With AI. JAMA Netw Open. 2025;8(6):e2515213. doi:10.1001/ jamanetworkopen.2025.15213
About the author
Dr. Tim Sandle is Head of QA Compliance at Bio Products Laboratory and a pharmaceutical microbiology consultant. In addition, Dr. Sandle is a visiting lecturer, specialising in sterility assurance and decontamination practices, at both the University of Manchester and University College London.
September 2026 I
www.clinicalservicesjournal.com 23
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85